Search

Your search keyword '"Faria, Mikaell Alexandre Gouvea"' showing total 12 results
Start Over Author "Faria, Mikaell Alexandre Gouvea"
12 results on '"Faria, Mikaell Alexandre Gouvea"'

1. Clinical factors associated with severity in patients with inflammatory bowel disease in Brazil based on 2-year national registry data from GEDIIB

Author

Fróes, Renata de Sá Brito, Andrade, Adriana Ribas, Faria, Mikaell Alexandre Gouvea, de Souza, Heitor Siffert Pereira, Parra, Rogério Serafim, Zaltman, Cyrla, dos Santos, Carlos Henrique Marques, Bafutto, Mauro, Quaresma, Abel Botelho, Santana, Genoile Oliveira, Luporini, Rafael Luís, de Lima Junior, Sérgio Figueiredo, Miszputen, Sender Jankiel, de Souza, Mardem Machado, Herrerias, Giedre Soares Prates, Junior, Roberto Luiz Kaiser, do Nascimento, Catiane Rios, Féres, Omar, de Barros, Jaqueline Ribeiro, Sassaki, Ligia Yukie, and Saad-Hossne, Rogerio

Published
2024
Full Text
View/download PDF

2. Vedolizumab in Mild-to-Moderate Crohn’s Disease Patients Naïve to Biological Therapy: A Multicentric Observational Study

Author

Dotti, Adriana Zanoni, primary, Magro, Daniela Oliveira, additional, Vilela, Eduardo Garcia, additional, Chebli, Julio Maria Fonseca, additional, Chebli, Liliana Andrade, additional, Steinwurz, Flavio, additional, Argollo, Marjorie, additional, Carvalho, Nayara Salgado, additional, Parente, Jose Miguel Luz, additional, Lima, Murilo Moura, additional, Parra, Rogério Serafim, additional, Perin, Ramir Luan, additional, Flores, Cristina, additional, Morsoletto, Eloá Marussi, additional, da Costa Ferreira, Sandro, additional, Ludvig, Juliano Coelho, additional, Kaiser Junior, Roberto Luiz, additional, Faria, Mikaell Alexandre Gouvea, additional, Nicollelli, Guilherme Mattioli, additional, Andrade, Adriana Ribas, additional, Queiroz, Natalia Sousa Freitas, additional, and Kotze, Paulo Gustavo, additional

Published
2023
Full Text
View/download PDF

5. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil

Author

Sassaki, Ligia Yukie, primary, Miszputen, Sender J, additional, Kaiser Junior, Roberto Luiz, additional, Catapani, Wilson R, additional, Bafutto, Mauro, additional, Scotton, António S, additional, Zaltman, Cyrla, additional, Baima, Julio Pinheiro, additional, Ramos, Hagata S, additional, Faria, Mikaell Alexandre Gouvea, additional, Gonçalves, Carolina D, additional, Guimaraes, Isabella Miranda, additional, Flores, Cristina, additional, Amarante, Heda M B S, additional, Nones, Rodrigo Bremer, additional, Parente, José Miguel Luz, additional, Lima, Murilo Moura, additional, Chebli, Júlio Maria, additional, Ferrari, Maria de Lourdes Abreu, additional, Campos, Julia F, additional, Sanna, Maria G P, additional, Ramos, Odery, additional, Parra, Rogério Serafim, additional, da Rocha, Jose J R, additional, Feres, Omar, additional, Feitosa, Marley R, additional, Caratin, Rosana Fusaro, additional, Senra, Juliana, additional, and Santana, Genoile Oliveira, additional

Published
2021
Full Text
View/download PDF

6. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil

Author

Zaltman, Cyrla, primary, Parra, Rogério Serafim, additional, Sassaki, Ligia Yukie, additional, Santana, Genoile Oliveira, additional, Ferrari, Maria de Lourdes Abreu, additional, Miszputen, Sender J, additional, Amarante, Heda M B S, additional, Kaiser Junior, Roberto Luiz, additional, Flores, Cristina, additional, Catapani, Wilson R, additional, Parente, José Miguel Luz, additional, Bafutto, Mauro, additional, Ramos, Odery, additional, Gonçalves, Carolina D, additional, Guimaraes, Isabella Miranda, additional, da Rocha, Jose J R, additional, Feitosa, Marley R, additional, Feres, Omar, additional, Saad-Hossne, Rogerio, additional, Penna, Francisco Guilherme Cancela, additional, Cunha, Pedro Ferrari Sales, additional, Gomes, Tarcia NF, additional, Nones, Rodrigo Bremer, additional, Faria, Mikaell Alexandre Gouvea, additional, Parente, Mírian Perpétua Palha Dias, additional, Scotton, António S, additional, Caratin, Rosana Fusaro, additional, Senra, Juliana, additional, and Chebli, Júlio Maria, additional

Published
2021
Full Text
View/download PDF

7. NEW BOWEL PREPARATION TECHNIQUE FOR COLONOSCOPY: CLINICAL TRIAL COMPARING AQUANET AND MANNITOL

Author

KAISER-JÚNIOR, Roberto Luiz, DE-QUADROS, Luiz Gustavo, FLAMINI-JÚNIOR, Mário, FARIA, Mikaell Alexandre Gouvea, CAMPO, Juan Carlos Ochoa, DE-OLIVEIRA, Vera Lúcia, and ZOTARELLI-FILHO, Idiberto José

Subjects
Clinical trial, Estudo clínico, Procedimentos clínicos, Propensity score, Clinical protocols, Pontuação de propensão, Estudo comparativo, Colonoscopia, Colonoscopy, Comparative study
Abstract

Background: Fifty-five percent of Americans aged 50-65 are submitted to colonoscopy. For over 65-year, this number increases to 64%. In Brazil, it is forecast that the population submitted to colonoscopy will grow, even though inadequate preparation is still a major problem. Aim: To analyze the quality of a new intestinal preparation technique, Aquanet EC-2000®, compared to oral Mannitol solution. Methods: This prospective longitudinal study enrolled 200 patients with indication for colonoscopy. The sample was randomly allocated to two groups of 100; one group received Aquanet EC-2000® to prepare for colonoscopy and the other Mannitol solution. The Boston scale was used to analyze the results. Results: As expected both preparations produced similar results with the bowel cleansing of the different regions of the colon being classified as Boston scale 3 (excellent) in most patients (p>0.05). Conclusion: The results of bowel preparation using Aquanet EC-2000® were similar to using Mannitol solution. RESUMO Racional: Cinquenta e cinco por cento dos norte-americanos entre 50-65 anos fazem colonoscopia. Acima de 65 anos o número foi de 64%. No Brasil, estima-se crescente aumento da população submetida à colonoscopia, apesar da preparação inadequada ainda ser um grande problema. Objetivo: Analisar e comparar a qualidade do novo método de preparo intestinal por meio do Aquanet EC-2000® frente ao uso de solução oral de Manitol. Método: Por randomização 200 pacientes foram divididos em dois grupos de 100. Um recebeu Aquanet EC-2000® e o outro Manitol. O presente estudo seguiu modelo prospectivo longitudinal por meio da seleção de 200 pacientes com indicação à colonoscopia, formando dois grupos de 100. Para analisar os resultados foi utilizada a escala de Boston. Resultados: Ambos os preparos foram estatisticamente significativos com p

Published
2018

8. Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn's disease NCT 03000296 Date 9 December 2016

Author

Ruiz, Milton Artur [UNESP], Kaiser, Roberto Luiz, De Quadros, Luiz Gustavo, Piron-Ruiz, Lilian, Peña-Arciniegas, Tatiana, Faria, Mikaell Alexandre Gouvea, Siqueira, Rubens Camargo, Pirozzi, Flavio Fontes, Kaiser, Fernanda Soubhia Liedtke, Burt, Richard K., Associação Portuguesa de Beneficência, Universidade de São Paulo (USP), Universidade Estadual Paulista (Unesp), Kaiser Clinica, and School of Medicine

Abstract

Made available in DSpace on 2018-12-11T16:49:51Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-10-06 Objective: The incidence of adverse events in myeloablative transplant protocols is high in refractory Crohn's disease; this study used low doses of cyclophosphamide. Fourteen patients were submitted to non-myeloablative autologous hematopoietic stem cell transplantation. Results: The average number of days of anemia (hemoglobin < 10 g/dL) was 5.4 ± 4.2 and 14 ± 2.4 in the mobilization and conditioning phases, respectively. The mean number of days of neutropenia (neutrophils < 0.5 × 109/L) in the mobilization phase was 1.7 ± 1.5 while it was 7.6 ± 1.4 in the conditioning phase. When comparing the conditioning and mobilization phases, there was an increased number days of leukopenia (white blood cells < 1.0 × 109/L), lymphocytopenia (lymphocytes < 0.5 × 109/L) and thrombocytopenia (platelets < 25 × 109/L). Crohn's Disease Activity Index values before the transplant ranged from 155 to 450.5 (mean 281.2 ± 79.0) and at 30 days after the procedures they ranged from 45.4 to 177 (mean 95.8 ± 35.4). Moreover, the procedure improved in overall quality of life of patients. Non-myeloablative autologous hematopoietic stem cell transplantation with lower doses of cyclophosphamide leads to lower rates of hematological toxicity and adverse events compared to protocols described in the literature. Trial registration NCT 03000296: Date 9 December 2016 Associação Portuguesa de Beneficência, St. Catarina Nucci Parise 760-SJ Rio Preto Faculdade de Medicina da Universidade de São Paulo Departamento de Genética Unesp Ibilce Sao Jose Do Rio Preto Kaiser Clinica Faculdade de Medicina Universidade de São Paulo Division of Immunotherapy Northwestern University Feinberg School of Medicine Departamento de Genética Unesp Ibilce Sao Jose Do Rio Preto

Published
2017

10. A Case of Adolescent Cronkhite-Canada Syndrome

Author

Faria, Mikaell Alexandre Gouvea, primary, Basaglia, Bruna, additional, Nogueira, Vinicius Quintiliano Moutinho, additional, de Mendonca, Tatiana Barros Gama Ferraz, additional, Kaiser Junior, Roberto Luiz, additional, Filho, Idiberto Jose Zotarelli, additional, and de Quadros, Luiz Gustavo, additional

Published
2018
Full Text
View/download PDF

11. Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn’s disease

Author

Ruiz, Milton Artur, primary, Kaiser, Roberto Luiz, additional, de Quadros, Luiz Gustavo, additional, Piron-Ruiz, Lilian, additional, Peña-Arciniegas, Tatiana, additional, Faria, Mikaell Alexandre Gouvea, additional, Siqueira, Rubens Camargo, additional, Pirozzi, Flavio Fontes, additional, Kaiser, Fernanda Soubhia Liedtke, additional, and Burt, Richard K., additional

Published
2017
Full Text
View/download PDF

12. NEW BOWEL PREPARATION TECHNIQUE FOR COLONOSCOPY: CLINICAL TRIAL COMPARING AQUANET AND MANNITOL.

Author

Kaiser-Júnior RL, DE-Quadros LG, Flamini-Júnior M, Faria MAG, Campo JCO, DE-Oliveira VL, and Zotarelli-Filho IJ

Subjects
Administration, Oral, Female, Humans, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Therapeutic Irrigation, Cathartics administration & dosage, Colonoscopy, Mannitol administration & dosage, Preoperative Care instrumentation, Preoperative Care methods
Abstract

Background: Fifty-five percent of Americans aged 50-65 are submitted to colonoscopy. For over 65-year, this number increases to 64%. In Brazil, it is forecast that the population submitted to colonoscopy will grow, even though inadequate preparation is still a major problem., Aim: To analyze the quality of a new intestinal preparation technique, Aquanet EC-2000®, compared to oral Mannitol solution., Methods: This prospective longitudinal study enrolled 200 patients with indication for colonoscopy. The sample was randomly allocated to two groups of 100; one group received Aquanet EC-2000® to prepare for colonoscopy and the other Mannitol solution. The Boston scale was used to analyze the results., Results: As expected both preparations produced similar results with the bowel cleansing of the different regions of the colon being classified as Boston scale 3 (excellent) in most patients (p>0.05)., Conclusion: The results of bowel preparation using Aquanet EC-2000® were similar to using Mannitol solution.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results